Explore the heterogeneity of pediatric functional constipation and IBS-C, the limitations of one-size-fits-all algorithms, and the importance of integrating dietary, behavioral, and psychosocial ...

A look back at the latest clinical trial updates for the pediatric population during June 2026. June brought a more concentrated set of clinical trial developments than earlier in the quarter, with ...

The PANDAS/PANS questionnaire is based on symptoms and comorbidities described in the literature and is a self-report completed by parents of children younger than 18. "Bottom line, previous surgery ...

An expert reviews the pediatric IBS-C label expansion for linaclotide, discusses how it addresses historical evidence gaps, and outlines practical considerations for patient selection, counseling, and ...

The FDA approved the first generic version of rifapentine tablets, previously marketed as Priftin. Rifapentine is indicated for active pulmonary tuberculosis in patients aged 12 years and older and ...

Any infant who consumed Nara Organics Whole Milk Organic Powdered Infant Formula and presents with constipation, poor feeding, hypotonia, loss of head control, or facial weakness should be evaluated ...

The US Food and Drug Administration (FDA) has cleared Dexcom's Stelo Glucose Biosensor System as the first over-the-counter continuous glucose monitor (CGM) for children, expanding the integrated CGM ...

The FDA has approved bemotrizinol as GRASE for sunscreen use at up to 6%, the first new OTC sunscreen active ingredient in approximately 20 years, cleared for adults and children 6 months and older.

Vertex reported phase 3 ALYFTREK data in children aged 2 to 5 years with cystic fibrosis and responsive CFTR genotypes. “The data we’re presenting today bring us to the cusp of our 25-year mission to ...